What Predicts the Successful Completion of Addiction Treatment?

Size: px
Start display at page:

Download "What Predicts the Successful Completion of Addiction Treatment?"

Transcription

1 What Predicts the Successful Completion of Addiction Treatment? Bushauna A Freeman -Dr. Metzger SUMR PROGRAM 2016 Philadelphia, PA August 17, 2016

2 Overview Background Addiction and Medication Assisted Treatment (MAT) Factors coinciding with the completion of MAT HIV Prevention Trials Network (HPTN): 058 Study Inclusion Criteria Demographic characteristics (Baseline) Results Conclusion Acknowledgments

3 Injection Drug Use and HIV Infection Globally, 36.7 million people living with HIV Approximately, 2.1 million people became newly infected with HIV Around 13 million people inject drugs ; about 1.7 million of them are living with HIV Injecting drug use accounts for approximately 10% of all new HIV infections Source: Joint United Nations Progamme on HIV/AIDS & W.H.O. (2015)

4 Heroin Heroin is one of the most commonly abused opioids Heroin usually appears as a white or brown powder that is used intravenously Source: National Institute on Drug Abuse Studies estimate that approximately 23% of all individuals who use heroin become dependent on it

5 ADDICTION = CHRONIC MEDICAL CONDITION 1. Biological aspect 2. Behavioral aspect Opioid use disorder requires attention to both--medication assisted treatment (MAT)

6 Barriers to Effective Medication Assisted Treatment (MAT) Access is limited globally Cost (varies according to the type of MAT needed) Insurance coverage Stigma Entry and retention in MAT

7 USE OF (SUBOXONE) IN THE HPTN 058 STUDY JAIDS, 2015

8 HPTN 058 Study Design HPTN 058: STUDY DESIGN Opiate injectors recruited from communities (4) and screened If not eligible, referred to local resources and terminated from study Short-Term Arm Suboxone detox for 3 wks., Then at 6 months if needed; plus 1 year counseling Long-Term Arm 1 year of Suboxone Administration and one year of counseling; Referral to local resources HIV testing and counseling Every 6 months Year 02

9 HPTN 058 Study Enrollment Sites Sites Chiang Mai, Thailand Urumuqi, Xinjiang Heng County, Guangxi Nanning, Guangxi

10 HPTN 058 Study SUBOXONE Partial opiate agonist with longer half-life Dosage 3x per week is sufficient (standard) Reduced risk of overdose Less severe withdrawal as opposed to other MAT s

11 HPTN 058 Study Behavioral Drug and Risk Counseling (BDRC) (1 year period) Rooted in cognitive behavioral therapy (changing patterns of thinking) Dr. Aaron Beck, University of Pennsylvania Focus on short term behavioral goals (partaking in less risky behaviors) Emphasis on drug use and related problems Relapse is anticipated and planned for 12 weekly individual sessions followed by nine monthly sessions, every four weeks

12 HPTN 058 Study Inclusion Criteria LT-MAT Age At least 18 yrs. of age yrs. Gender Male/Female Marital Status Married, or living with partner; Single, Divorced, Widowed Education Status None to 9+ yrs.

13 HPTN 058 Study Baseline Drug Use Characteristics Long Term- Medication Assisted Treatment LT-MAT Percent meeting criteria for opiate dependence n=623 (100%) Age of first injection (Mean) 26.1 Years of injection (Mean) 7.7 Opiate injection in prior 30 days (mean) 77.7

14 Common Factors that Inhibit Treatment Completion Age Gender Education Employment Poly Drug Use Sexual Risk Actions

15 What factors were actually associated with medication and counseling completion?

16 Age Medication Completion (p<.005) Counseling Completion (p<.05) Incomplete Completed Incomplete Completed Total Total Age Range Intervals Age Range Intervals Complete Adherence = attending 12 Weeks, 9 months counseling sessions; all medication visits

17 Gender Medication Completion (p=ns) Counseling Completion (p=ns) Incomplete Completed Incomplete Completed Male Female Total 0 Male Female Total Gender Gender Complete Adherence = attending 12 Weeks, 9 months counseling sessions; all medication visits

18 Employment 70 Medication Completion 70 Counseling Completion 60 (p=ns) 60 (p<.05) Incomplete Completed Incomplete Completed No Job Regular Employment Total 0 No Job Regular Employment Total Employment Status Employment Status Complete Adherence = attending 12 Weeks, 9 months counseling sessions; all medication visits

19 Education Status 80 Medication Completion 80 Counseling Completion 70 (p<.001) 70 (p<.005) Incomplete Completed Incomplete Completed No Education 1-8 yrs. 9 or more yrs. Total 0 No Education 1-8 yrs. 9 or more yrs. Total Years of Schooling Years of Schooling Complete Adherence = attending 12 Weeks, 9 months counseling sessions; all medication visits

20 Poly Drug Use Medication Completion (p=ns) Counseling Completion (p=ns) Incomplete Completed 40 Incomplete Completed One Drug Two or more Drugs Total 0 One Drug Two or more Drugs Total # of Drugs Abused # of Drugs Abused Complete Adherence = attending 12 Weeks, 9 months counseling sessions; all medication visits

21 Sexual Risk Actions Medication Completion Counseling Completion (p=ns) 60 (p=ns) Sexual Practices in the past month Incomplete Completed Sexual Practices in the past month Incomplete Completed 0 Yes No Total 0 Yes No Total Vaginal/Anal Sex? Vaginal/Anal Sex? Complete Adherence = attending 12 Weeks, 9 months counseling sessions; all medication visits

22 Counseling Completion by Medication Completion (p<.001) 80 Medication Visits Rate Incomplete Completed Some Sessions All Sessions Total Completion of Counseling Treatment

23 Reasons for Missed Visits TOTAL UNABLE TO SCHEDULE WINDOW UNABLE TO CONTACT PARTICIPANT INCACERATED PARTICIPANT DECEASED 14.7% 52.7% 51.3% 43.2% 48.1% 36.0% 11.8% 20.9% 21.4% 18.5% 31.6% 25.8% 20.0% 0.3% 19.5% % 0.1% 0.0% 0.1% 86.2%

24 RESULTS SUMMARIZED Age Gender Education Employment All Factors Significant Factors Age Education Completion of Counseling sessions by completion of Medication visits Poly Drug Use Sexual Risk Actions Completion of Counseling sessions by completion of Medication visits

25 Conclusion Age and education were significantly associated with medication completion Age, education and employment were significantly associated with counseling completion Counseling and medication completion were highly correlated Data is consistent with the maturing out hypothesis which explains that most drug users tend to reduce and eliminate drug use as they age The data indicated that the majority of participants who completed all counseling sessions, also completed their medication visits - This finding proves to be the most significant and would indicate that the best incentive for completion of treatment would be to offer some form of medication in addition to counseling services

26 Lessons Learned The ability to analyze and interpret data from a clinical trial The correlation between these significant factors and completion of treatment proves that there is in fact a connection, but these factors do not necessarily cause treatment outcomes The necessity for the expansion of Medication Assisted Treatment (MAT) within the U.S. Improved understanding and appreciation for the field of epidemiology

27 Acknowledgements David Metzger, Ph.D., Director Danielle Fiore, Data Analyst Tiffany Dominique, BA

PATH FOR TRIPLES BUSHAUNA FREEMAN MICHAEL BLANK, P.I. SUMR PROGRAM 2016 PHILADELPHIA, PA AUGUST 18, 2016

PATH FOR TRIPLES BUSHAUNA FREEMAN MICHAEL BLANK, P.I. SUMR PROGRAM 2016 PHILADELPHIA, PA AUGUST 18, 2016 PATH FOR TRIPLES BUSHAUNA FREEMAN MICHAEL BLANK, P.I. SUMR PROGRAM 2016 PHILADELPHIA, PA AUGUST 18, 2016 OVERVIEW HIV/AIDS on a global, national, and state level Background and Study Design The Intervention

More information

Research Article Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People Who Inject Drugs in China and Thailand

Research Article Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People Who Inject Drugs in China and Thailand Hepatitis Research and Treatment, Article ID 296958, 5 pages http://dx.doi.org/10.1155/2014/296958 Research Article Prevalence and Seroincidence of Hepatitis B and Hepatitis C Infection in High Risk People

More information

Substance Abuse Suboxone Treatment

Substance Abuse Suboxone Treatment Substance Abuse Suboxone Treatment Program Waterbury Hospital Infectious Disease Clinic Richard Smith, LCSW Leonard Savage, Consumer Steven I. Aronin, MD FACP, Program Director Ryan White All Grantee Meeting

More information

Place of addiction-informed comprehensive treatment in HIV care

Place of addiction-informed comprehensive treatment in HIV care Place of addiction-informed comprehensive treatment in HIV care Cecile Denis, PhD Center for Studies of Addiction, University of Pennsylvania, Philadelphia, USA University of Bordeaux, Bordeaux, France

More information

Vivitrol Drug Court and Medication Assisted Treatment

Vivitrol Drug Court and Medication Assisted Treatment Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment

More information

The Importance of Psychological Treatment and Behavioral Support

The Importance of Psychological Treatment and Behavioral Support The Importance of Psychological Treatment and Behavioral Support Michael W. Otto, PhD Department of Psychological and Brain Science Boston University Conflicts and Acknowledgements No industry funding

More information

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers

CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF. Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers CHANGING CULTURE, BUILDING A SYSTEM, SUPPORTING PATIENTS AND STAFF Andrew Suchocki, MD, MPH Medical Director Clackamas Health Centers DISCLOSURES None. OVERVIEW Basic description- context and system overview

More information

DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION. Biweekly Call December 14, 2016

DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION. Biweekly Call December 14, 2016 DATA-DRIVEN JUSTICE: DISRUPTING THE CYCLE OF INCARCERATION Biweekly Call December 14, 2016 Data-Driven Justice Initiative Implementing Medication Assisted Treatment Programs for Justice Involved Populations

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

Implementing Medication Assisted Treatment Programs for Justice Involved Populations

Implementing Medication Assisted Treatment Programs for Justice Involved Populations Implementing Medication Assisted Treatment Programs for Justice Involved Populations THE MIDDLESEX SHERIFF S OFFICE MATADOR PROGRAM Sheriff Peter J. Koutoujian October 31, 2016 1 Professional Background

More information

Project Connections Buprenorphine Program

Project Connections Buprenorphine Program Project Connections Buprenorphine Program Program & Client Summary 2010-2017 Behavioral Health Leadership Institute November 2017 November 2017 1 Table of Contents I. Overview of the Project Connections

More information

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP

Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Injectable naltrexone (XR-NTX) A RETROSPECTIVE STUDY OF ITS ACCEPTANCE IN A COMMUNITY RECOVERY SETTING BRIANNE FITZGERALD MSN, PMHNP, CARN-AP Overview Gavin Foundation Injectable naltrexone Community report

More information

Fighting Today s Opioid Epidemic

Fighting Today s Opioid Epidemic Fighting Today s Opioid Epidemic Establish in 1966 as a Public Health Department Location: Rock Falls, IL/Whiteside County Population: Whiteside County 2015--57,079 Serving Rural IL: Primarily Whiteside,

More information

Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2

Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives. Session 2 Opportunities and Challenges for Nursing in WA State Medicaid Expansion and other New Initiatives Session 2 1 Learning Objectives Learn about WA State strategies for addressing the opioid crisis, including

More information

Middlesex Sheriff s Office NCSL Atlantic States Fiscal Leaders Meeting Presentation

Middlesex Sheriff s Office NCSL Atlantic States Fiscal Leaders Meeting Presentation Middlesex Sheriff s Office NCSL Atlantic States Fiscal Leaders Meeting Presentation Tackling the High Cost of Prison Health Care Peter J. Koutoujian, Sheriff Saturday, February 25, 2017 The Middlesex Sheriff

More information

Medication-Assisted Treatment (MAT) Overview

Medication-Assisted Treatment (MAT) Overview Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for

More information

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016

What Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016 What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)

More information

A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail

A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail The Warren Alpert Medical School of Brown University A Randomized Trial of Continued Methadone Maintenance Vs. Detoxification in Jail Michelle McKenzie, MPH Bradley Brockmann, JD Nickolas Zaller, PhD Josiah

More information

Prescription Drug Overdose

Prescription Drug Overdose 2017 Prescription Drug Overdose Stark County Pilot Project Report 1 Table of Contents Acknowledgements 3 Executive Summary 4 Project Flow Chart 5 Project Implementation 6 Project Results 8 Lessons Learned

More information

Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya

Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya Uptake of and Retention on HIV Pre-Exposure Prophylaxis (PrEP) among adolescent girls and young women in Kenya LINA DIGOLO, C OCHIENG, A NGUNJIRI, M KIRAGU, J KYONGO, L OTISO, W MUKOMA 8 T H I N T E R

More information

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D.

QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. 2017 State Targeted Response to the Opioid Crisis Grants QUARTERLY PROVIDER MEETING MARCH 9, 2017 SUZANNE BORYS, ED.D. H.R.6-21st Century Cures Act The 21st Century Cures Act is a United States law enacted

More information

Treatment Can Work. SELECT A TOPIC...

Treatment Can Work.  SELECT A TOPIC... Page 1 of 8 SELECT A TOPIC..... NIDA Home > Drug Abuse and Addiction: One of America's Most Challenging Public Health Problems Treatment Can Work Drug Treatment Works Research has revealed a number of

More information

Targeted Outreach & Other Strategies for Increasing HCV Testing

Targeted Outreach & Other Strategies for Increasing HCV Testing Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department

More information

Barnstable County Sheriff s Office. Vivitrol Pre-Release Program. Dr. Steven Descoteaux, MD Director of Health Services

Barnstable County Sheriff s Office. Vivitrol Pre-Release Program. Dr. Steven Descoteaux, MD Director of Health Services Barnstable County Sheriff s Office Vivitrol Pre-Release Program Dr. Steven Descoteaux, MD Director of Health Services Jessica Burgess,MSN, RN Assistant Director of Health Services Gail Dufault, LPN Transitional

More information

Program Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree:

Program Application. Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree: DATE: I. PERSONAL INFORMATION Name: SSN: Address: City: State: Zip: Phone: Date of Birth: Age: Occupation: Highest Grade Completed/College/Degree: Other skills/training: What tools can you use: Farm or

More information

Initiation and engagement in addiction treatment integrated into primary care: the role of gender

Initiation and engagement in addiction treatment integrated into primary care: the role of gender Initiation and engagement in addiction treatment integrated into primary care: the role of gender Alexander Y. Walley, MD, MSc Co-Authors: Kaylyn Duerfeldt, Joe Palmisano, Amy Sorensen-Alawad, Chris Chaisson,

More information

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016

Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Montgomery County Poisoning Death Review, 2016: Quarter I Updated June 20, 2016 Prepared by: Robert G. Carlson, Ph.D., Professor and Director, Project Director Linna Li, M.S., Data Manager Raminta Daniulaityte,

More information

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities

Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Care in the Face of the Opioid Epidemic: How Yale University and Yale New Haven Hospital are Reaching Underserved Communities Jeanette M. Tetrault, MD FACP FASAM Associate Professor of Medicine Program

More information

Vivitrol/Suboxone. Comparison Study Summary

Vivitrol/Suboxone. Comparison Study Summary Vivitrol/Suboxone Comparison Study Summary Lee, J. D., Nunes, E. V., Novo, P., Bachrach, K., Bailey, G. L., Bhatt, S., & King, J. (2017). Comparative effectiveness of extended-release naltrexone versus

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

Enhanced Housing Placement Assistance (EHPA): Baseline Characteristics of Homeless PLWHA in New York City

Enhanced Housing Placement Assistance (EHPA): Baseline Characteristics of Homeless PLWHA in New York City Enhanced Housing Placement Assistance (EHPA): Baseline Characteristics of Homeless PLWHA in New York City Rachel Johnson, MPH John Rojas, MPA NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE North

More information

Maryland Medicaid and Opioid Epidemic

Maryland Medicaid and Opioid Epidemic Maryland Medicaid and Opioid Epidemic Sara Cherico Senior Health Policy Analyst Office of the Secretary Maryland Department of Health and Mental Hygiene June 23, 2016 National Opioid Addiction and Overdose

More information

Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS

Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS Treatment Works, Kentucky: An Overview of Substance Abuse Treatment Outcomes from KTOS Robert Walker, M.S.W., L.C.S.W. University of Kentucky Center on Drug and Alcohol Research Kentucky Substance Abuse

More information

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH

Buprenorphine Order Set and Rapid Access Referral. Copyright 2017, CAMH 2 Buprenorphine Order Set and Rapid Access Referral 1 Agenda Problem Identification / Identification Importance / Importance Baseline Workflow Baseline Workflow Baseline Data Baseline Data Objectives Solution

More information

Opioid dependence and buprenorphine treatment

Opioid dependence and buprenorphine treatment Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions

More information

Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach. Van L. King, MD

Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach. Van L. King, MD Best Practice Models for Opioid Treatment Programs Motivated Stepped Care: An Adaptive Treatment Approach Van L. King, MD UT Health, Department of Psychiatry Grand Rounds November 15, 2016 Addiction Treatment

More information

GOALS AND OBJECTIVES

GOALS AND OBJECTIVES SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES

More information

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations

Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Medication Assisted Treatment for Opioid Use Disorders and Veteran Populations Kamala Greene Genece, Ph.D. VP, Clinical Director Phoenix Houses of New York Benjamin R. Nordstrom, M.D., Ph.D. President

More information

Ryan White Programs Provision of Substance Use Treatment

Ryan White Programs Provision of Substance Use Treatment Ryan White Programs Provision of Substance Use Treatment Amanda Bowes and Magalie Lerman NASTAD AGENDA An overview of substance use treatment needs among people living with HIV (PLWH) Allowable uses of

More information

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story

Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Pennsylvania Coordinated Medication Assisted Treatment: A Penn State and Pennsylvania Psychiatric Institute Story Sarah Sharfstein Kawasaki, MD Director of Addictions Services, Pennsylvania Psychiatric

More information

C.A.A.R.E. WCPA/WPLF 2016 Winter Conference 4/5/2018. Greenfield Prior to C.A.A.R.E. Cops Assisting Addiction Recovery. Greenfield Police Department

C.A.A.R.E. WCPA/WPLF 2016 Winter Conference 4/5/2018. Greenfield Prior to C.A.A.R.E. Cops Assisting Addiction Recovery. Greenfield Police Department C.A.A.R.E. Cops Assisting Addiction Recovery Greenfield Police Department As a nation, we are losing far too many lives due to the current opioid abuse crisis. This is a situation that demands immediate

More information

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine

FY17 SCOPE OF WORK TEMPLATE. Name of Program/Services: Medication-Assisted Treatment: Buprenorphine FY17 SCOPE OF WORK TEMPLATE Name of Program/Services: Medication-Assisted Treatment: Buprenorphine Procedure Code: Modification of 99212, 99213 and 99214: 99212 22 99213 22 99214 22 Definitions: Buprenorphine

More information

Closing the Loop in Treating Opioid Addiction:

Closing the Loop in Treating Opioid Addiction: Closing the Loop in Treating Opioid Addiction: Integrating MAT into Prison and Jail Health Systems May 9, 2018 Webinar Housekeeping All lines are muted This session will be recorded To ask a question:

More information

Chiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT

Chiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT Chiang Mai University/Johns Hopkins University HIV/AIDS Research on VCT David Celentano, Professor of Epidemiology May 26, 2005 Scope of the CMU/JHU Collaborative HIV/AIDS Research Agenda HIV/AIDS research

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Statewide

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Statewide New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Statewide Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

Addictive Disorders Assessment Form

Addictive Disorders Assessment Form Addictive Disorders Assessment Form Thorpe Recovery Centre Telephone: 780.875.8890 Fax: 780.875.2161 Email: info@thorperecoverycentre.org CLIENT INFORMATION First Name Middle Name Last Name Phone Number

More information

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016

The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine. March 10, 2016 The Role of Primary Care Teams and the Medical Neighborhood in Addressing the Opioid Crisis in Maine March 10, 2016 Objectives Review current state of opioid crisis in Maine Briefly review physiology of

More information

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE

HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE HIV POSITIVE YOUTH: LINKAGE & RETENTION IN CARE Site C Youth clinic HIV care pathway DAY 1 Test HIV + PIMA point of care CD4 count in in 3-5 days initiation + in session 3 session 4 1 month Youth Club

More information

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS

TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS TREATING OPIOID ADDICTION IN HOMELESS POPULATIONS Challenges and Opportunities Providing Medication Assisted Treatment (Buprenorphine) August 18, 2016 SPEAKERS TODAY Nilesh Kalyanaraman, MD, Chief Health

More information

Outlook and Outcomes Fiscal Year 2011

Outlook and Outcomes Fiscal Year 2011 Baltimore Substance Abuse Systems, Inc. Outlook and Outcomes Fiscal Year 2011 Baltimore City Greg Warren, President Compiled July 2012 BSAS Outlook and Outcomes is the first edition of a planned annual

More information

Vivitrol Vs. Suboxone

Vivitrol Vs. Suboxone Vivitrol Vs. Suboxone Vivitrol - Naltrexone Indicated for opiate dependence and alcohol withdrawal pure antagonist 380mg once every 4 weeks IM Peak plasma concentration in 2 hrs, followed by a second peak

More information

Latest Research on Addiction and Treatment

Latest Research on Addiction and Treatment Latest Research on Addiction and Treatment Joshua D Lee MD MSc joshua.lee@nyumc.org / @DrJoshuaDLee Associate Professor NYU School of Medicine, Department of Population Health Disclosures, LeeJD Grants:

More information

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates

Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates Substance Use Disorders (SUDs) and Medication Assisted Treatment (MAT) for Opiates What is MAT? Medication Assisted Treatment (MAT) is the use of medications, in addition to counseling, cognitive behavioral

More information

By Richard Harris, Assistant Director. May 21, 2010

By Richard Harris, Assistant Director. May 21, 2010 Youth and Opiates: Trends and Interventions in Oregon By Richard Harris, Assistant Director May 21, 2010 Youth and Opiates Prescription drugs including opiates increasingly becoming part of the youth and

More information

Medication Assisted Treatment

Medication Assisted Treatment Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hudson County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hudson County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Hudson County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE

PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE PRESCRIPTION DRUG ABUSE: THE NATIONAL PERSPECTIVE September 20, 2013 Association of State and Territorial Health Officials Annual Meeting R. Gil Kerlikowske Director of National Drug Control Policy National

More information

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC

Medications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are

More information

Medication Assisted Treatment. Nicole Gastala, MD

Medication Assisted Treatment. Nicole Gastala, MD Medication Assisted Treatment Nicole Gastala, MD Objectives Training Goals: To enhance the understanding of the participants in use of medication assisted therapy To increase the knowledge of participants

More information

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs

Medication Assisted Treatment. Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Medication Assisted Treatment Karen Drexler, MD National Mental Health Program Director-Substance Use Disorders Department of Veterans Affairs Disclosures Employed by the Department of Veterans Affairs

More information

Opiate Use among Ohio Medicaid Recipients

Opiate Use among Ohio Medicaid Recipients Opiate Use among Ohio Medicaid Recipients July 12, 2012 Ohio Colleges of Medicine Government Resource Center The Ohio State University College of Public Health Sponsored by The Ohio Department of Alcohol

More information

Evaluation of Integration of Medication-assisted Treatment for Injection Drug Users into HIV Medical Care in Leningrad Oblast, Russia

Evaluation of Integration of Medication-assisted Treatment for Injection Drug Users into HIV Medical Care in Leningrad Oblast, Russia American International Health Alliance Project Closeout Report Evaluation of Integration of Medication-assisted Treatment for Injection Drug Users into HIV Medical Care in Leningrad Oblast, Russia Agreement

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Passaic County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Passaic County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Passaic County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

Last Name Required to create unique record number (URN) in CAREWare and encrypted unique client ID (UCI) that is sent to HRSA for the RSR

Last Name Required to create unique record number (URN) in CAREWare and encrypted unique client ID (UCI) that is sent to HRSA for the RSR Required Fields in Minnesota CAREWare The following table summarizes the fields that are required in Minnesota CAREWare. It also tells you whether the field is cross-provider (viewable/editable by all

More information

Middlesex Sheriff s Office

Middlesex Sheriff s Office Middlesex Sheriff s Office MATADOR Program White Paper April 2018 THE MATADOR PROGRAM Utilizing Incarceration to Tackle Addiction and Save Lives: Implementing Medication Assisted Treatment Programs in

More information

Opioid Stewardship and Managing the Opioid Crisis: A Health-Care Perspective

Opioid Stewardship and Managing the Opioid Crisis: A Health-Care Perspective Opioid Stewardship and Managing the Opioid Crisis: A Health-Care Perspective February 13, 2018 Frank Vocci, PhD New Therapies on the Horizon The planners, editors, faculty and reviewers of this activity

More information

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model

Agenda. 1 Opioid Addiction in the United States. Evidence-based treatments for OUD. OUD Treatment: Best Practices. 4 Groups: Our Model Agenda 1 Opioid Addiction in the United States 2 Evidence-based treatments for OUD OUD Treatment: Best Practices 4 Groups: Our Model 2 Groups is a national network of clinics providing affordable, evidencebased

More information

Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations

Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations Pharmacotherapy for Opioid Dependence in Correctional Settings: Research Findings and Recommendations Robert P. Schwartz, M.D. Rschwartz@friendsresearch.org Friends Research Institute www.friendsresearch.org

More information

Child Welfare and MOMS: Building Partnerships to Improve Care

Child Welfare and MOMS: Building Partnerships to Improve Care Child Welfare and MOMS: Building Partnerships to Improve Care Goals Develop collaborative partnerships between MOMS pilot sites and child welfare agencies: Facilitate successful outcomes for clients Jointly

More information

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County

BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County BERNALILLO COUNTY OPIOID ABUSE ACCOUNTABILITY SUMMIT Turning the Curve on Opioid Abuse in Bernalillo County NMPHA Annual Conference April 2, 2014 Marsha McMurray-Avila Coordinator, Bernalillo County Community

More information

HARM REDUCTION & TREATMENT. Devin Reaves MSW

HARM REDUCTION & TREATMENT. Devin Reaves MSW HARM REDUCTION & TREATMENT Devin Reaves MSW The mission of PAHRC is to promote the health, dignity, and human rights of individuals who use drugs and communities impacted by drug use. Recognizing that

More information

gatewaycorrections.org TCU & Gateway Foundation 9/23/2014 Disclosures Topics Covered Opioid Use Disorders & the CJ System

gatewaycorrections.org TCU & Gateway Foundation 9/23/2014 Disclosures Topics Covered Opioid Use Disorders & the CJ System Mid-America ATTC Regional Conference Medication Assisted Treatment: Promoting Tools for Successful Recovery September 23, 2014 The Use of Medication-Assisted Treatment with Justice-Involved Clients Kevin

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Buprenorphine Implant for Treatment of Opioid Dependence File Name: Origination: Last CAP Review: Next CAP Review: Last Review: buprenorphine_implant_for_treatment_of_opioid_dependence

More information

GOVERNMENT OF BERMUDA Ministry of Culture and Social Rehabilitation THE BERMUDA DRUG TREATMENT COURT PROGRAMME

GOVERNMENT OF BERMUDA Ministry of Culture and Social Rehabilitation THE BERMUDA DRUG TREATMENT COURT PROGRAMME GOVERNMENT OF BERMUDA Ministry of Culture and Social Rehabilitation Department of Court Services THE BERMUDA DRUG TREATMENT COURT PROGRAMME Background information Drug Courts were created first in the

More information

Injecting Drug Users: A Global Problem. Roger Detels, M.D., M.S.

Injecting Drug Users: A Global Problem. Roger Detels, M.D., M.S. Injecting Drug Users: A Global Problem Roger Detels, M.D., M.S. Global Areas of Drug User- Europe Transmitted HIV North America (U.S., Canada) South America Southeast Asia (Thailand, Myanmar, Vietnam,

More information

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS

Trigger. Myths About the Use of Medication in Recovery BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module VI Counseling Buprenorphine Patients Myths About the Use of Medication in Recovery! Patients are still addicted!

More information

RADIO AS A TOOL IN COMMUNITY ENGAGEMENT AND EDUCATION

RADIO AS A TOOL IN COMMUNITY ENGAGEMENT AND EDUCATION Note to file: The author of this article (Joel Odondi) has been in charge of community education, recruitment of study participants and retention of enrolled participants in Kisumu site. This included

More information

Substance Abuse Overview 2012 Warren County

Substance Abuse Overview 2012 Warren County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2012 Warren County Prepared by Limei Zhu Department of Human Services Division of Mental Health and Addiction Services Office of Research,

More information

Substance Abuse Overview 2015 Passaic County

Substance Abuse Overview 2015 Passaic County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2015 Passaic County Prepared by Limei Zhu Department of Human Services Division of Mental Health and Addiction Services Office of Planning,

More information

Confronting the Opioid Epidemic: Suboxone in Primary Care

Confronting the Opioid Epidemic: Suboxone in Primary Care Confronting the Opioid Epidemic: Suboxone in Primary Care Kami Harless, MD 1 The Opioid Epidemic 2 The Opioid Epidemic 3 Washington Epidemic 4 King County Epidemic 5 King County Epidemic 6 Outline Opioid

More information

Opioid Use Disorder Treatment Initiation in Diverse Settings

Opioid Use Disorder Treatment Initiation in Diverse Settings Opioid Use Disorder Treatment Initiation in Diverse Settings Sarah Wakeman, MD, FASAM Medical Director, Mass General Substance Use Disorder Initiative Assistant Professor, Harvard Medical School Disclosures

More information

Quality assurance in pharmacotherapy with methadone

Quality assurance in pharmacotherapy with methadone Quality assurance in pharmacotherapy with methadone Dr. Emilis Subata Vilnius Centre for Addictive Disorders Psychiatry Clinic of Vilnius University emilis.subata@vplc.lt Outline of the presentation Introduction

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Essex County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Essex County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Essex County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

ORGANIZATION OF AMERICAN STATES

ORGANIZATION OF AMERICAN STATES ORGANIZATION OF AMERICAN STATES INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION FIRST INTER-REGIONAL FORUM OF EU-LAC CITIES: PUBLIC POLICIES IN DRUG TREATMENT April 2 5, 2008 Santo Domingo, Dominican Republic

More information

Creating a Drug Free Workplace

Creating a Drug Free Workplace Creating a Drug Free Workplace Victor Parziale, BS, CRS, ARISE Intern Program Supervisor DrugFreeWorkplacePA.org October 26, 2017 Paid for with Pennsylvania Taxpayer Dollars Overview Introduction The Cost

More information

Women over 50-HIV/AIDS and Hepatitis September 8, 2013 United States Conference on AIDS

Women over 50-HIV/AIDS and Hepatitis September 8, 2013 United States Conference on AIDS Women over 50-HIV/AIDS and Hepatitis September 8, 2013 United States Conference on AIDS www.aids-alliance.org www.theaidsinstitute.org PRESENTERS Michelle Scavnicky, MS, Director of Education and Capacity

More information

Amanda Archer, BS, MPH

Amanda Archer, BS, MPH Amanda Archer, BS, MPH The Need Hepatitis C Canton City Stark County From 2010 to 2016, Stark County has seen a 37.4% increase in the total number of newly diagnosed Hepatitis C. Canton City shows a 30%

More information

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond

Disclosures. Objectives 2/5/2018. Women and opioid use disorder: Optimizing care during pregnancy and beyond Women and opioid use disorder: Optimizing care during pregnancy and beyond Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP Ashley L. Hodges, PhD, CRNP, WHNP-BC Disclosures Dr. Fogger has nothing to

More information

Substance Abuse Overview 2012 Gloucester County

Substance Abuse Overview 2012 Gloucester County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2012 Gloucester County Prepared by Limei Zhu Department of Human Services Division of Mental Health and Addiction Services Office of

More information

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Warren County

New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Warren County New Jersey Drug and Alcohol Abuse Treatment Substance Abuse Overview 2016 Warren County Department of Human Services Division of Mental Health and Addiction Services Office of Planning, Research, Evaluation

More information

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-18-17AUZ]

Billing Code: P DEPARTMENT OF HEALTH AND HUMAN SERVICES. Centers for Disease Control and Prevention. [30Day-18-17AUZ] This document is scheduled to be published in the Federal Register on 06/18/2018 and available online at https://federalregister.gov/d/2018-12971, and on FDsys.gov Billing Code: 4163-18-P DEPARTMENT OF

More information

The Opioid Crisis: What Can Physicians Do About It?

The Opioid Crisis: What Can Physicians Do About It? The Opioid Crisis: What Can Physicians Do About It? Richard S. Schottenfeld, M.D. Professor and Chair, Department of Psychiatry and Behavioral Sciences 2018 Louis J. Kolodner Memorial Lecture Disclosures

More information

Last Name First Middle Date of Birth Age. Residence Address City State Zip Code

Last Name First Middle Date of Birth Age. Residence Address City State Zip Code The following necessary information will help make your first session most productive. Please PRINT and fill out this form COMPLETELY. DEMOGRAPHICS Date: Last Name First Middle Date of Birth Age Residence

More information

HIV Screening in Behavioral Health Settings: The Need is Clear

HIV Screening in Behavioral Health Settings: The Need is Clear HIV Screening in Behavioral Health Settings: The Need is Clear Alyssa A. Bittenbender, MPH Program Director, Arizona AIDS Education and Training Center University of Arizona College of Medicine MISSION

More information

Community Needs Assessment. June 26, 2013

Community Needs Assessment. June 26, 2013 Community Needs Assessment June 26, 2013 Agenda Purpose Methodology for Collecting Data Geographic Area Demographic Information Community Health Data Prevalence of Alcohol & Drug Use Utilization data Findings

More information

Safe Practices and Action Items

Safe Practices and Action Items Safe Practices and Action Items Karen F Marlowe, Pharm D, BCPS Certified Pain Educator Auburn University Harrison School of Pharmacy University of South Alabama School of Medicine Case Study A 58 year

More information

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018

PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 PITTSBURGH MERCY: COMPREHENSIVE INTEGRATED CARE JUNE 6, 2018 AN ENHANCED MEDICAL HOME MODEL FOR THE SMI POPULATION Comprehensive Care Patient Centered Care Coordinated Care Accessible Services Quality

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information